Enhance your knowledge with our comprehensive guide and curated study materials.
Reversible loss of consciousness with analgesia + amnesia + immobility + attenuation of autonomic responses
Allows painless surgical procedures with patient safety
Hypnosis → loss of consciousness (propofol, thiopentone)
Analgesia → pain relief (opioids, N₂O)
Amnesia → loss of memory (benzodiazepines)
Immobility → skeletal muscle relaxation (inhalational agents, NM blockers)
Use of multiple drugs in combination to achieve all components with minimal toxicity
Advantages:
↓ Dose of individual drugs
↓ Side effects
Better hemodynamic stability
Example:
Induction → propofol
Analgesia → fentanyl
Muscle relaxation → vecuronium
Maintenance → sevoflurane
Defined as:
→ Alveolar concentration of anaesthetic that prevents movement in 50% of patients to surgical stimulus
Inverse relation with potency
Lower MAC = more potent drug
Additive for multiple agents
↓ MAC: age ↑, hypothermia, opioids
↑ MAC: chronic alcohol use, hyperthermia
Indicates solubility of anaesthetic in blood
Low coefficient → rapid induction & recovery (desflurane, sevoflurane)
High coefficient → slow induction (halothane)
Reflects lipid solubility → potency
Follows Meyer–Overton rule
Higher oil:gas ratio → ↑ potency → ↓ MAC
| Parameter | Clinical Meaning | Example |
|---|---|---|
| MAC ↓ | High potency | Halothane |
| Blood:gas ↓ | Fast induction | Desflurane |
| Oil:gas ↑ | High potency | Isoflurane |
Surgical stimulus → patient response
50% no movement → defines MAC
Graph: concentration vs response curve
Anxiolysis → reduce fear
Sedation → calm patient
Analgesia → reduce pain perception
Antisialagogue → ↓ secretions
Prevent aspiration → ↓ gastric acidity & volume
Reduce reflex responses
Drugs: midazolam, diazepam
Actions:
Anxiolysis
Amnesia
Sedation
Mechanism:
GABA-A receptor potentiation
Drugs: fentanyl, morphine
Actions:
Strong analgesia
↓ anaesthetic requirement
Adverse:
Respiratory depression
Drugs: atropine, glycopyrrolate
Actions:
↓ salivary & bronchial secretions
Prevent vagal bradycardia
Drugs:
ondansetron (5-HT3 blocker)
metoclopramide (D2 blocker)
Use:
Prevent postoperative nausea & vomiting
Drugs:
ranitidine (H2 blocker)
omeprazole (PPI)
Actions:
↓ gastric acid secretion
↓ risk of aspiration pneumonitis
| Class | Drug | Purpose |
|---|---|---|
| Benzodiazepine | Midazolam | Anxiolysis + amnesia |
| Opioid | Fentanyl | Analgesia |
| Anticholinergic | Glycopyrrolate | ↓ secretions |
| Antiemetic | Ondansetron | Prevent vomiting |
| H2 blocker | Ranitidine | ↓ acid |
Patient anxiety → Sedative
↓
Pain risk → Opioid
↓
Secretions ↑ → Anticholinergic
↓
Aspiration risk → H2 blocker/PPI
↓
PONV risk → Antiemetic
MAC ↓ = potency ↑
Low blood:gas → fastest induction (desflurane)
Balanced anaesthesia = safest approach
Midazolam → amnesia (very common viva)
Glycopyrrolate preferred over atropine → less CNS effect
Ondansetron → best for PONV prevention
From start of anaesthesia → loss of consciousness
Features:
Analgesia present
Patient conscious initially
Memory gradually lost
Clinical:
Useful for minor procedures
From loss of consciousness → onset of regular respiration
Features:
Delirium, agitation
Irregular breathing
Vomiting, risk of aspiration
Increased reflexes
Clinical significance:
Dangerous stage → must be passed rapidly
Divided into 4 planes
Regular respiration begins
Loss of eyelash reflex
Suitable for minor surgery
Loss of corneal reflex
Relaxation of muscles
Regular respiration
Suitable for most surgeries
Intercostal muscle paralysis begins
Shallow respiration
Pupillary dilation begins
Diaphragmatic breathing only
Severe CNS depression
Approaching overdose
Respiratory failure
Cardiovascular collapse
Fatal if untreated
| Stage | Features | Clinical Significance |
|---|---|---|
| I | Analgesia, conscious | Minor procedures |
| II | Excitement, delirium | Dangerous |
| III | Surgical anaesthesia | Ideal stage |
| IV | Medullary paralysis | Fatal |
Induction
↓
Stage I (Analgesia)
↓
Stage II (Excitement) ⚠️
↓
Stage III (Surgical) ✅
↓
Stage IV (Overdose) ❌
Nitrous oxide (N₂O)
Weak anaesthetic
Strong analgesic
Xenon (conceptual)
NMDA antagonist
Very expensive
Halothane
Isoflurane
Sevoflurane
Desflurane
Used for maintenance of anaesthesia
Differ in:
Potency (MAC)
Induction speed
Toxicity profile
Propofol
Thiopentone
Etomidate
Rapid onset
Used for induction
Ketamine
Produces dissociative anaesthesia
Analgesia + amnesia
↑ BP, ↑ HR (unique)
Midazolam
Sedation + amnesia
Used in premedication & procedures
Fentanyl
Potent analgesic
Used in balanced anaesthesia
| Class | Drugs | Key Feature |
|---|---|---|
| Inhalational gas | Nitrous oxide | Analgesic |
| Volatile liquid | Sevoflurane | Rapid induction |
| IV induction | Propofol | Smooth recovery |
| Dissociative | Ketamine | ↑ BP, analgesia |
| Benzodiazepine | Midazolam | Amnesia |
| Opioid | Fentanyl | Strong analgesia |
General Anaesthetics
→ Inhalational
→ Gases
→ Volatile liquids
→ Intravenous
→ Induction agents
→ Dissociative
→ Benzodiazepines
→ Opioids
Stage II = dangerous → rapid induction required
Stage III plane 2 = ideal for surgery
Stage IV = overdose (medullary failure)
Propofol = most commonly used induction agent
Ketamine = only anaesthetic that ↑ BP & HR
Nitrous oxide = good analgesic but weak anaesthetic
Most general anaesthetics (propofol, thiopentone, volatile agents)
Mechanism:
↑ GABA-mediated Cl⁻ influx
→ Hyperpolarization of neurons
→ CNS depression
Result:
Sedation
Hypnosis
Amnesia
Drugs: ketamine, nitrous oxide
Mechanism:
Block glutamate (excitatory neurotransmitter)
↓ excitatory transmission
Result:
Analgesia
Dissociative anaesthesia
Especially in spinal cord
Enhances inhibitory neurotransmission
Leads to:
Immobility
Muscle relaxation
Opens K⁺ channels → K⁺ efflux
Causes:
Hyperpolarization
Reduced neuronal excitability
Anaesthetic potency ∝ lipid solubility
Acts by altering cell membrane fluidity
Direct interaction with:
Ion channels
Receptors (GABA, NMDA)
| Mechanism | Drugs | Effect |
|---|---|---|
| GABA ↑ | Propofol, thiopentone | Sedation |
| NMDA ↓ | Ketamine, N₂O | Analgesia |
| Glycine ↑ | Volatile agents | Immobility |
| K⁺ channels ↑ | Volatile agents | CNS depression |
Anaesthetic drug
↓
GABA ↑ / NMDA ↓
↓
Neuronal inhibition
↓
Loss of consciousness + analgesia + immobility
Transfer pathway:
Alveoli → Blood → Brain → Other tissues
Goal:
Rapid attainment of equilibrium between alveoli and brain
Measured by blood:gas partition coefficient
Low solubility → rapid induction & recovery
Example: desflurane, sevoflurane
High solubility → slow induction
Example: halothane
↑ ventilation → ↑ anaesthetic delivery
→ Faster induction
↑ cardiac output:
Slows induction (more uptake into blood)
↓ cardiac output:
Faster induction
High inspired concentration → faster rise in alveolar concentration
Leads to:
Faster induction
Occurs when nitrous oxide is given with another anaesthetic
Rapid uptake of N₂O → ↓ alveolar volume
→ ↑ concentration of second gas
Faster induction of second agent
Rapid diffusion of N₂O from blood → alveoli
Dilutes oxygen in alveoli
Hypoxia during recovery
Give 100% O₂ after stopping N₂O
After IV administration:
Drug moves from brain → muscle → fat
Short duration of action (thiopentone, propofol)
Recovery due to redistribution, not metabolism
Propofol, thiopentone
Halothane (significant metabolism)
Desflurane, sevoflurane
Nitrous oxide
| Factor | Effect on Induction |
|---|---|
| Blood solubility ↓ | Faster |
| Ventilation ↑ | Faster |
| Cardiac output ↑ | Slower |
| Concentration ↑ | Faster |
Inspired concentration ↑
↓
Alveolar concentration ↑
↓
Blood concentration ↑
↓
Brain concentration ↑
↓
Anaesthesia
GABA potentiation = most important mechanism
Ketamine = NMDA blocker → dissociative anaesthesia
Low blood:gas = fastest induction (desflurane)
Second gas effect = N₂O phenomenon
Diffusion hypoxia → prevented by 100% O₂
IV agents act short due to redistribution, not metabolism
Eyelash reflex → lost early (Stage III)
Corneal reflex → lost in deeper anaesthesia
Pupils:
Constricted → adequate anaesthesia
Dilated → light anaesthesia or hypoxia
Regular breathing → adequate depth
Irregular respiration → Stage II (dangerous)
Shallow/slow respiration → deep anaesthesia
Progressive relaxation with depth
Complete relaxation in surgical anaesthesia
Tachycardia, hypertension → light anaesthesia
Hypotension → deep anaesthesia
Based on processed EEG signals
Provides numerical value (0–100)
100 → fully awake
40–60 → ideal surgical anaesthesia
<40 → deep anaesthesia
Prevents awareness during surgery
Helps titrate anaesthetic dose
Measures electrical activity of brain
Awake → high frequency, low amplitude
Anaesthesia → low frequency, high amplitude
Deep anaesthesia → burst suppression
Most anaesthetics ↓ brain metabolism
Neuroprotective effect
Volatile agents → ↑ ICP
Propofol, thiopentone → ↓ ICP
Volatile anaesthetics → vasodilation → ↑ CBF
IV agents → ↓ CBF
Enflurane → ↓ threshold → may cause seizures
Others generally anticonvulsant
Most agents:
↓ myocardial contractility
↓ blood pressure
Exception:
Ketamine
↑ sympathetic tone
↑ BP, ↑ HR
Dose-dependent respiratory depression
↓ tidal volume
↓ respiratory rate
Loss of airway reflexes
↓ renal blood flow (secondary to hypotension)
↓ GFR
↓ hepatic blood flow
Halothane:
Risk of hepatotoxicity
Relaxation of uterine smooth muscle
May lead to:
Postpartum hemorrhage
| System | Effect |
|---|---|
| CNS | ↓ CMRO₂, ↑/↓ ICP |
| CVS | ↓ BP (except ketamine ↑) |
| Respiratory | Depression |
| Renal | ↓ GFR |
| Hepatic | ↓ blood flow |
| Uterus | Relaxation |
Inhalational anaesthetics:
Enhance action of non-depolarizing NM blockers
Mechanism:
↓ sensitivity of post-synaptic membrane
↓ ACh release
Direct depression of:
Neuromuscular transmission
Skeletal muscle tone
Lower dose of muscle relaxants required
Risk of:
Prolonged paralysis
Respiratory depression
Anaesthetic agent
↓
↓ ACh release + ↓ receptor sensitivity
↓
Enhanced muscle relaxation
↓
↓ skeletal muscle tone
BIS 40–60 = ideal anaesthesia
Ketamine = only agent increasing BP & HR
Propofol ↓ ICP → DOC in neurosurgery
Volatile agents ↑ CBF → ↑ ICP
Respiratory depression = dose dependent
Anaesthetics potentiate muscle relaxants → dose reduction needed
Potentiates GABA-A receptor
Rapid induction (within seconds)
Smooth recovery
Antiemetic effect
Induction agent (DOC)
Maintenance (TIVA)
ICU sedation
Hypotension
Respiratory depression
Pain on injection
Fastest recovery → day-care surgery drug of choice
GABA-A receptor activation
Ultra-short acting (due to redistribution)
Rapid induction
Induction
Control of seizures
Respiratory depression
Hypotension
Accumulation on repeated use
NMDA receptor antagonist
Dissociative anaesthesia
Strong analgesia
Bronchodilation
↑ BP, ↑ HR (sympathomimetic)
Trauma patients
Asthma
Short painful procedures
Emergence delirium
Hallucinations
Only anaesthetic that increases BP
GABA-A receptor potentiation
Minimal cardiovascular depression
Hemodynamically stable
Induction in cardiac patients
Adrenal suppression
Myoclonus
Drug of choice in shock / unstable patients
Volatile inhalational anaesthetic
Potent anaesthetic
Smooth induction
Halothane hepatitis
Arrhythmias
Myocardial depression
Rarely used now due to hepatotoxicity
Moderate potency
Stable cardiac profile
Vasodilation → ↓ BP
Preserves cardiac output
Widely used for maintenance
Low blood:gas coefficient
Rapid induction & recovery
Non-irritant
Pleasant odor
Paediatric induction (DOC)
Smooth and fast acting
Very low blood solubility
Fastest induction & recovery
Airway irritation
Cough, laryngospasm
Best for day-care surgeries
Inhalational gas
Weak anaesthetic
Strong analgesic
Rapid onset
Minimal metabolism
Diffusion hypoxia
Megaloblastic anemia (B12 inhibition)
Used as adjunct in balanced anaesthesia
| Drug | Key Feature | Major Advantage | Important Adverse Effect |
|---|---|---|---|
| Propofol | Rapid onset | Smooth recovery | Hypotension |
| Thiopentone | Ultra-short acting | Rapid induction | Accumulation |
| Ketamine | NMDA blocker | ↑ BP, bronchodilation | Hallucinations |
| Etomidate | Hemodynamic stability | Safe in shock | Adrenal suppression |
| Halothane | Potent | Smooth induction | Hepatitis |
| Isoflurane | Stable CVS | Maintenance | Hypotension |
| Sevoflurane | Fast induction | Pediatric use | Minimal toxicity |
| Desflurane | Fastest recovery | Day-care surgery | Airway irritation |
| Nitrous oxide | Analgesic | Rapid action | Diffusion hypoxia |
Hemodynamically unstable → Etomidate
↓
Asthma / trauma → Ketamine
↓
Routine induction → Propofol
↓
Pediatric → Sevoflurane
↓
Day-care surgery → Desflurane
Propofol = most commonly used induction agent
Ketamine = dissociative anaesthesia + ↑ BP
Etomidate = DOC in shock
Sevoflurane = DOC in pediatrics
Desflurane = fastest recovery
Nitrous oxide = strong analgesic, weak anaesthetic
Halothane = hepatotoxic → obsolete
Dose-dependent ↓ in:
Respiratory rate
Tidal volume
Mechanism:
Depression of medullary respiratory center
Hypoventilation
Hypercapnia
Apnea (high doses)
Due to:
↓ myocardial contractility
Peripheral vasodilation
Propofol
Volatile anaesthetics
Especially with halothane
Mechanism:
Sensitization of myocardium to catecholamines
Ventricular arrhythmias possible
Features:
Hallucinations
Agitation
Vivid dreams
Benzodiazepines (midazolam)
| Effect | Mechanism | Drug Example |
|---|---|---|
| Respiratory depression | CNS depression | Propofol |
| Hypotension | Vasodilation | Isoflurane |
| Arrhythmias | Catecholamine sensitivity | Halothane |
| Delirium | NMDA block | Ketamine |
Genetic mutation in ryanodine receptor (RYR1)
Triggered by:
Volatile anaesthetics
Succinylcholine
↑ Ca²⁺ release from sarcoplasmic reticulum
→ Sustained muscle contraction
→ ↑ heat production
Hyperthermia
Muscle rigidity
Tachycardia
Hypercapnia
Dantrolene (drug of choice)
Cooling measures
Oxygen support
Trigger (anaesthetic)
↓
RYR mutation → ↑ Ca²⁺
↓
Muscle rigidity + heat production
↓
Hyperthermia + acidosis
↓
Dantrolene treatment
Type I (mild) → transient liver enzyme rise
Type II (severe) → immune-mediated hepatic necrosis
Repeated exposure
Obesity
Female sex
Formation of trifluoroacetylated proteins
→ Immune-mediated injury
Metabolism of certain volatile agents
↑ serum fluoride ions
Renal tubular damage
Reaction with soda lime → formation of Compound A
Nephrotoxicity (experimental relevance)
Pungent odor
Causes:
Cough
Laryngospasm
Not preferred for induction
Inactivates vitamin B12
→ Impairs DNA synthesis
Megaloblastic anemia
Neuropathy
| Drug | Toxicity | Mechanism |
|---|---|---|
| Halothane | Hepatitis | Immune-mediated |
| Sevoflurane | Compound A toxicity | Soda lime reaction |
| Desflurane | Airway irritation | Direct irritation |
| N₂O | Megaloblastic anemia | B12 inhibition |
| Volatile agents | Malignant hyperthermia | Ca²⁺ dysregulation |
Malignant hyperthermia → treat with dantrolene
Halothane → hepatitis (classic viva)
Sevoflurane → Compound A (nephrotoxicity concept)
Desflurane → airway irritation → not for induction
Nitrous oxide → B12 inhibition → anemia
Propofol → hypotension + respiratory depression
Autosomal dominant disorder
Mutation in ryanodine receptor (RYR1) → skeletal muscle Ca²⁺ channel
Volatile anaesthetics:
Halothane, isoflurane, sevoflurane, desflurane
Depolarizing muscle relaxant:
Succinylcholine
Abnormal ↑ Ca²⁺ release from sarcoplasmic reticulum
→ Sustained muscle contraction
→ ↑ ATP consumption
→ Heat production + metabolic acidosis
Early signs
Hypercapnia (↑ CO₂ – earliest sign)
Tachycardia
Late signs
Muscle rigidity
Hyperthermia
Acidosis
Rhabdomyolysis
Dantrolene (Drug of choice)
Blocks Ca²⁺ release from SR
100% oxygen
Active cooling
Correction of acidosis (NaHCO₃)
| Feature | Description |
|---|---|
| Cause | RYR1 mutation |
| Trigger | Volatile agents, succinylcholine |
| Early sign | Hypercapnia |
| Key drug | Dantrolene |
Trigger drug
↓
RYR mutation → ↑ Ca²⁺
↓
Muscle contraction
↓
↑ Heat + acidosis
↓
Dantrolene + supportive care
Inhalational anaesthetics:
Potentiate non-depolarizing NM blockers
↓ ACh release
↓ sensitivity of post-synaptic receptors
Lower dose of muscle relaxant required
Risk of prolonged paralysis
Additive CNS depression
↑ sedation
↑ respiratory depression
↑ hypotension
Combined use leads to:
Enhanced anaesthetic depth
Reduced dose requirement
Increased risk of overdose
| Combination | Effect |
|---|---|
| Anaesthetic + NM blocker | ↑ muscle relaxation |
| Anaesthetic + opioid | ↑ analgesia + respiratory depression |
| Anaesthetic + benzodiazepine | ↑ sedation |
Rapid-acting IV agents:
Propofol (most common)
Thiopentone
Etomidate
Inhalational agents:
Isoflurane
Sevoflurane
Desflurane
Requirements:
Rapid onset
Rapid recovery
Propofol
Desflurane
Requirements:
Minimal fetal depression
Rapid recovery
Nitrous oxide
Low-dose volatile agents
Requirements:
↓ intracranial pressure (ICP)
Propofol
Thiopentone
| Situation | Drug of Choice |
|---|---|
| Induction | Propofol |
| Maintenance | Isoflurane |
| Day-care surgery | Desflurane |
| Shock | Etomidate |
| Asthma | Ketamine |
| Neurosurgery | Propofol |
Volatile anaesthetics:
Cause uterine relaxation
↓ uterine tone
→ Postpartum hemorrhage risk
Nitrous oxide (analgesia)
Low-dose inhalational agents
High-dose volatile anaesthetics → excessive uterine relaxation
Anaesthetic drug
↓
Uterine relaxation
↓
↓ uterine tone
↓
Risk of hemorrhage
Malignant hyperthermia → earliest sign = hypercapnia
Dantrolene = life-saving drug
Volatile agents potentiate muscle relaxants
Propofol = DOC for induction & neurosurgery
Desflurane = best for day-care surgery
Ketamine = preferred in asthma & shock
Volatile agents → uterine relaxation → PPH risk
Many volatile anaesthetics → cerebral vasodilation → ↑ cerebral blood flow (CBF)
→ ↑ ICP
Worsening of:
Brain edema
Intracranial hypertension
Herniation risk
Propofol
Thiopentone
→ ↓ CBF and ↓ ICP
Most anaesthetics:
↓ myocardial contractility
↓ blood pressure
Severe hypotension
Organ hypoperfusion
Etomidate
Minimal cardiovascular depression
Anaesthetics may cause:
Arrhythmias
Myocardial depression
Halothane → sensitizes myocardium to catecholamines → arrhythmias
Avoid arrhythmogenic agents
Careful monitoring required
| Condition | Risk | Preferred Drug |
|---|---|---|
| Raised ICP | ↑ ICP | Propofol |
| Shock | Hypotension | Etomidate |
| Cardiac instability | Arrhythmia | Isoflurane (relatively safe) |
Raised ICP → Propofol
↓
Shock → Etomidate
↓
Cardiac instability → Avoid halothane
Leakage of anaesthetic gases:
Nitrous oxide
Volatile anaesthetics
Faulty equipment
Poor scavenging systems
Headache
Fatigue
Reduced alertness
Reproductive issues (infertility, miscarriage)
Possible hepatotoxicity
Proper ventilation
Use of gas scavenging systems
Regular equipment maintenance
| Exposure | Effect |
|---|---|
| Acute | Headache, dizziness |
| Chronic | Reproductive risk |
| High exposure | Organ toxicity |
First effective general anaesthetic
Good analgesia and muscle relaxation
Highly flammable
Slow induction and recovery
Irritating to airway
Rapid induction
Pleasant odor
Severe hepatotoxicity
Cardiac arrhythmias
Sudden cardiac death
Both are obsolete due to:
Safer modern anaesthetics
Better control and fewer adverse effects
| Drug | Advantage | Major Problem |
|---|---|---|
| Ether | Effective anaesthesia | Flammable |
| Chloroform | Rapid induction | Cardiotoxic |
Ether / Chloroform
↓
Halothane
↓
Modern agents (Sevoflurane, Desflurane)
Raised ICP → avoid volatile agents, use propofol
Shock → etomidate is safest
Halothane → arrhythmogenic
Chronic anaesthetic exposure → occupational hazard
Ether = flammable, chloroform = cardiotoxic
Modern anaesthesia = safer, controlled, rapid recovery
| Feature | Inhalational Anaesthetics | IV Anaesthetics |
|---|---|---|
| Route | Inhaled through lungs | Intravenous |
| Main use | Maintenance | Induction |
| Onset | Depends on blood:gas solubility | Very rapid |
| Recovery | Depends on ventilation, solubility, duration | Mainly by redistribution initially |
| Control of depth | Easy by changing inspired concentration | Less easily controlled |
| Examples | N₂O, sevoflurane, desflurane, isoflurane | Propofol, thiopentone, etomidate, ketamine |
| Common toxicity | Respiratory depression, hypotension, malignant hyperthermia | Respiratory depression, hypotension |
| Special point | Useful for long procedures | Useful for rapid induction |
| Drug | Approximate MAC | Potency |
|---|---|---|
| Halothane | 0.75 | High |
| Isoflurane | 1.15 | Moderate-high |
| Sevoflurane | 2 | Moderate |
| Desflurane | 6 | Low |
| Nitrous oxide | >100 | Very low |
Key rule:
Lower MAC = higher potency
Higher MAC = lower potency
| Coefficient | Meaning | Clinical Importance |
|---|---|---|
| Blood:gas coefficient | Solubility in blood | Determines speed of induction and recovery |
| Low blood:gas | Poorly soluble in blood | Fast induction and recovery |
| High blood:gas | Highly soluble in blood | Slow induction and recovery |
| Oil:gas coefficient | Lipid solubility | Determines potency |
| High oil:gas | More lipid soluble | More potent, lower MAC |
| Feature | Propofol | Thiopentone | Etomidate | Ketamine |
|---|---|---|---|---|
| Mechanism | GABA-A potentiation | GABA-A potentiation | GABA-A potentiation | NMDA blockade |
| Onset | Rapid | Rapid | Rapid | Rapid |
| Recovery | Smooth, rapid | Slower after repeated doses | Rapid | May have delirium |
| CVS effect | Hypotension | Hypotension | Minimal depression | ↑ BP, ↑ HR |
| Respiration | Depression | Depression | Mild depression | Less depression |
| Analgesia | Poor | Poor | Poor | Good |
| Special use | Day-care, TIVA | Induction, seizures | Shock, cardiac instability | Trauma, asthma |
| Important adverse effect | Pain on injection, hypotension | Accumulation | Adrenal suppression | Emergence delirium |
| Drug | Induction/Recovery | Airway Irritation | Important Toxicity | Key Use |
|---|---|---|---|---|
| Halothane | Slow-moderate | Non-irritant | Hepatitis, arrhythmia | Mostly obsolete |
| Isoflurane | Moderate | Irritant | Hypotension | Maintenance |
| Sevoflurane | Rapid | Non-irritant | Compound A concept | Pediatric induction |
| Desflurane | Fastest | Irritant | Cough, laryngospasm | Day-care surgery |
| System | Main Effect |
|---|---|
| CNS | ↓ CMRO₂; volatile agents may ↑ CBF and ICP |
| CVS | Hypotension due to myocardial depression/vasodilation; ketamine increases BP |
| Respiratory | Dose-dependent respiratory depression |
| Liver | ↓ hepatic blood flow; halothane hepatitis |
| Kidney | ↓ renal blood flow and GFR; fluoride nephrotoxicity concept |
| Uterus | Relaxation → postpartum hemorrhage risk |
| NMJ | Potentiates non-depolarizing muscle relaxants |
| Stage | Name | Features | Importance |
|---|---|---|---|
| Stage I | Analgesia | Analgesia, consciousness gradually lost | Minor procedures |
| Stage II | Excitement | Delirium, irregular respiration, vomiting risk | Dangerous stage |
| Stage III | Surgical anaesthesia | Regular breathing, muscle relaxation | Desired stage |
| Stage IV | Medullary paralysis | Respiratory failure, CVS collapse | Overdose |
| Drug | Induction | Recovery | Key Point |
|---|---|---|---|
| Propofol | Very rapid | Smooth and rapid | Best routine induction |
| Thiopentone | Rapid | Delayed with repeated doses | Redistribution initially |
| Etomidate | Rapid | Rapid | CVS stable |
| Ketamine | Rapid | Emergence reactions | Analgesic |
| Sevoflurane | Rapid | Rapid | Pediatric use |
| Desflurane | Rapid | Fastest | Day-care surgery |
| Adverse Effect | Common Drug/Group |
|---|---|
| Respiratory depression | Propofol, thiopentone, volatile agents |
| Hypotension | Propofol, volatile agents |
| Arrhythmias | Halothane |
| Emergence delirium | Ketamine |
| Hepatitis | Halothane |
| Airway irritation | Desflurane |
| Diffusion hypoxia | Nitrous oxide |
| Megaloblastic anemia | Nitrous oxide |
| Adrenal suppression | Etomidate |
| Malignant hyperthermia | Volatile agents + succinylcholine |
| Feature | Details |
|---|---|
| Genetic defect | Ryanodine receptor mutation |
| Triggers | Halothane, isoflurane, sevoflurane, desflurane, succinylcholine |
| Earliest sign | Hypercarbia |
| Other features | Muscle rigidity, tachycardia, hyperthermia, acidosis |
| Treatment | Dantrolene |
| Supportive care | 100% O₂, cooling, correction of acidosis |
| Clinical Situation | Preferred Drug |
|---|---|
| Routine induction | Propofol |
| Day-care surgery | Propofol / desflurane |
| Shock/cardiac instability | Etomidate |
| Asthma/bronchospasm | Ketamine |
| Pediatric inhalational induction | Sevoflurane |
| Neurosurgery/raised ICP | Propofol / thiopentone |
| Balanced anaesthesia analgesic adjunct | Nitrous oxide / fentanyl |
| Obstetric analgesia | Nitrous oxide cautiously |
| Drug Class | Examples | Role |
|---|---|---|
| Benzodiazepines | Midazolam, diazepam | Anxiolysis, sedation, amnesia |
| Opioids | Fentanyl, morphine | Analgesia, ↓ anaesthetic requirement |
| Anticholinergics | Atropine, glycopyrrolate | ↓ secretions, prevent vagal bradycardia |
| Antiemetics | Ondansetron, metoclopramide | Prevent nausea and vomiting |
| H2 blockers / PPIs | Ranitidine, omeprazole | ↓ gastric acidity, aspiration prophylaxis |
Anaesthetic agents
↓
GABA-A potentiation
→ ↑ Cl⁻ influx
→ neuronal hyperpolarization
→ hypnosis, sedation, amnesia
Anaesthetic agents
↓
NMDA inhibition
→ ↓ glutamate excitatory transmission
→ analgesia, dissociative anaesthesia
Induction
↓
Stage I — Analgesia
↓
Stage II — Excitement
↓
Stage III — Surgical anaesthesia
↓
Stage IV — Medullary paralysis
Inspired anaesthetic
↓
Alveoli
↓
Pulmonary blood
↓
Arterial blood
↓
Brain
↓
Anaesthesia
Blood solubility ↓
→ faster induction and recovery
Alveolar ventilation ↑
→ faster induction
Cardiac output ↑
→ slower induction
Inspired concentration ↑
→ faster induction
Anaesthetic concentration increases
↓
Movement response decreases
↓
Concentration at which 50% patients do not move
↓
MAC
Nitrous oxide rapidly enters blood
↓
Alveolar volume decreases
↓
Concentration of second anaesthetic gas rises
↓
Faster induction of second gas
Stop nitrous oxide
↓
N₂O rapidly diffuses from blood to alveoli
↓
Dilutes alveolar oxygen
↓
Hypoxia
↓
Prevent with 100% oxygen
Volatile anaesthetic / succinylcholine
↓
RYR1 mutation
↓
Excess Ca²⁺ release from sarcoplasmic reticulum
↓
Sustained muscle contraction
↓
Hypercarbia + rigidity + acidosis + hyperthermia
↓
Dantrolene
Premedication
↓
IV induction agent
↓
Opioid analgesic
↓
Muscle relaxant
↓
Inhalational maintenance
↓
Safe surgical anaesthesia with reduced toxicity
IV bolus
↓
Brain uptake
↓
Rapid anaesthesia
↓
Redistribution to muscle
↓
Redistribution to fat
↓
Recovery from single dose
Get the full PDF version of this chapter.